Congratulations - #KasiaGryglewska ‼️ We keep continuing our work on #longCovid , including hospitalized #patients at high #CVD risk‼️💪 #HeartFailure2024
The May 2024 edition of the #HeartSounds is live! Thanks DrThomasCuisset for a quick catch-up on what was hot at #EuroPCR PCRonline 🫀, not to mention #SCAI2024 , #hrs2024 #ESOC2024 , & #HeartFailure2024
tctmd.com/audio/may-2024…
Grateful to present our results on #ReDS and #Vscan (handheld ultrasound) for #heartfailure patients in #primarycare at #HeartFailure2024 🇵🇹!
Many thanks to Josefine and Pernilla from Capio Johannelund primary care centre, and our #LiU team members for the wonderful support🤗
👩⚕️Nuestra residente, Lucía Palma, presenta el trabajo: Clinical, prognosis and economic outcomes in a novel cardio-renal-metabolic unit en #HeartFailure2024
🔴 Antiarrhythmic Drug Classifications
#Cardioed #Cardiology #CardiogenicShock #meded #medtwitterWhat #MedTwitter #CardioEd #medx #medEd #CardioTwitter #cardiotwitter #MedX #MedEd #HeartFailure2024 #cardiology #cardiotwiteros #FOAMed
Participación de nuestros facultativos y residentes del en el Congreso de Heart Failure 2024 en Lisboa! 🌍❤️
👩⚕️🧑⚕️ Ainhoa Robles Clara Jimenez Rubio Luis García Rodríguez
#HeartFailure2024 #SaludCardiovascular
escardio.org/Congresses-Eve…
#HeartFailure2024
Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease ( MIRACLE)
Non-significant reductions in ACR with balcinrenone plus dapagliflozin observed with no dose response
Muthu Vaduganathan
#HeartFailure2024
CD8+ Cytotoxic T-cells Drive Outcome in Chronic Inflammator Cardiomyopathy
unexplored role of CD8+ T-cells in InfI-CMP
Selectively targeting the CD8+ T-cell population may further benefit the treatment of Infl-CMP patients
Straight out of #HeartFailure2024 , it’s time to launch the #HFA_ESC #HFA_YOUNG JOURNAL CLUB
1st edition is on 5 JUNE 6PM CEST will discuss: the PUSH-AHF trial
Register now: bit.ly/44J2jxw
Aficamten for the treatment of symptomatic oHCM. A new kid in the block showing significant improvement in symptoms, exercise capacity and quality of life compared to placebo in oHCM patients 👏🏻👏🏻👏🏻 #HeartFailure2024 #sequoia_hcm European Society of Cardiology
I love such meetings, so great networking and so many ideas during so short FTF meetings💪. #HeartFailure2024
#HeartFailure2024
Diuresis Efficacy in Ambulatory Chronic Heart Failure Patients:
Intra-Patient Comparison of Three Diuretic Regimens (DEA-HF Clinical Trial)
Intravenous furosemide plus metolazone resulted in a significantly higher natriuresis when compared to IV furosemide
#HeartFailure2024
PRAISE HFpEF DM
Glucagon-like Peptide-1 Receptor Agonist In obeSE Heart Failure with Preserved Ejection Fraction with type 2 diabetes
In DM and obese HFpEF, GLP1-RA at diabetes management associated with reduction in the composite of HFH and mortality
#HFAmotions #HeartFailure2024 #20yearsHFA
Exciting conversation about HFA Congress with the President of the European Society of Cardiology Thomas Luscher 🤩🤩🤩
Leclercq christophe GICC Manel EL BLIDI Frederik H. Verbrugge Novi Tham
A deeper dive into the NT-proBNP changes in ATTRibute-CM ( #acoramidis vs placbo)
Presented at #HeartFailure2024
#CardioTwitter
#amyloidosis
Check out the highlights in Heart Failure for #CSANZ2024 in Perth - early-bird closing Monday 3 June. Watch video👉bit.ly/3R3AVod
Register Now!👉csanzasm.com
#CardioTwitter David Playford Dr Girish Dwivedi #heartfailure2024